Data as of November 13, 2026

Dalfampridine ER 10 mg Tablet

DALFAMPRIDINE

Brand: Dalfampridine

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$21.96/ fill$0.37 / EA
Cost Plus Drugs (retail)
$11.42/ fill$0.19 / EA
VA Big4
$57.19/ fill$0.95 / EA
FUL
$47.67/ fill$0.80 / EA
AMP
$27.24/ fill$0.45 / EA
Medicaid FFS
$43.42/ fill
Medicaid MCO
$128.36/ fill

Sources: cms/nadac:price-ladder · costplusdrugs/price-list · va/fss-drug-prices:normalized · cms/ful:generic-ceiling · cms/sdud. Cost Plus prices as of 2026-11-13

What's in the reimbursement

Ingredient cost (59.9 units/fill)$21.96
Dispensing fee & other (state-fixed, not margin)$21.46
Total reimbursed per fill$43.42

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 16 fee-for-service states, 23 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology